Cargando…

Is cystic fibrosis a risk factor for COVID-19 infection or related complications?

Detalles Bibliográficos
Autor principal:	Athanazio, Rodrigo A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747155/ https://www.ncbi.nlm.nih.gov/pubmed/36651443 http://dx.doi.org/10.36416/1806-3756/e20220445

Ejemplares similares

Early COVID-19 infection after lung transplantation in a patient with cystic fibrosis
por: Athanazio, Rodrigo Abensur, et al.
Publicado: (2020)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Maternal and Perinatal Outcomes in Pregnant Women with Cystic Fibrosis
por: Osmundo Junior, Gilmar de Souza, et al.
Publicado: (2019)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

Shifting Landscape of Airway Infection in Early Cystic Fibrosis
por: Hoppe, Jordana E., et al.
Publicado: (2019)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Brazilian consensus on non-cystic fibrosis bronchiectasis
por: Pereira, Mônica Corso, et al.
Publicado: (2019)

Bronchiectasis: moving from an orphan disease to an unpleasant socioeconomic burden
por: Athanazio, Rodrigo Abensur
Publicado: (2021)

Diagnosis of cystic fibrosis-related diabetes: too early or too late?
por: Sovtic, Aleksandar
Publicado: (2022)

Scoring tools to monitor risk of disease progression in patients with cystic fibrosis
por: Donadio, Márcio Vinícius Fagundes, et al.
Publicado: (2020)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions
por: Miller, Aaron C., et al.
Publicado: (2020)

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Steps toward Cell Therapy for Cystic Fibrosis
por: Koh, Kyung Duk, et al.
Publicado: (2020)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Where Is the Cystic Fibrosis Transmembrane Conductance Regulator?
por: Barbry, Pascal, et al.
Publicado: (2021)

Brazilian Guidelines for Nutrition in Cystic Fibrosis
por: Neri, Lenycia de Cassya Lopes, et al.
Publicado: (2022)

Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
por: Terlizzi, Vito, et al.
Publicado: (2022)

Is PI3K a Villain in Cystic Fibrosis?
por: Natarajan, Viswanathan
Publicado: (2020)

Infections in cystic fibrosis
por: Marks-Austin, Kathy A., et al.
Publicado: (1995)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
por: Yadav, Ruchi, et al.
Publicado: (2023)

Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes
por: Kempegowda, Punith, et al.
Publicado: (2020)

Nutrition in Cystic Fibrosis: as important as the management of pulmonary disease
por: Adde, Fabíola Villac
Publicado: (2015)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qqrcro2gmssnnq4tfu6vqsks2n